FDA Inspection 1267578 — BioAccess, Inc.

BioAccess, Inc. — FEI 1000513050

The FDA completed an inspection of BioAccess, Inc. on Apr 22, 2025 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 22, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Baltimore, MD (United States)

Citations

IDCFRDescription
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.